Clinical Presentation of Parvovirus B19 Infection in Adults Living with HIV/AIDS: A Case Series

Viruses. 2023 May 8;15(5):1124. doi: 10.3390/v15051124.

Abstract

Parvovirus B19 (B19V) infection varies clinically depending on the host's immune status. Due to red blood cell precursors tropism, B19V can cause chronic anemia and transient aplastic crisis in patients with immunosuppression or chronic hemolysis. We report three rare cases of Brazilian adults living with human immunodeficiency virus (HIV) with B19V infection. All cases presented severe anemia and required red blood cell transfusions. The first patient had low CD4+ counts and was treated with intravenous immunoglobulin (IVIG). As he remained poorly adherent to antiretroviral therapy (ART), B19V detection persisted. The second patient had sudden pancytopenia despite being on ART with an undetectable HIV viral load. He had historically low CD4+ counts, fully responded to IVIG, and had undiagnosed hereditary spherocytosis. The third individual was recently diagnosed with HIV and tuberculosis (TB). One month after ART initiation, he was hospitalized with anemia aggravation and cholestatic hepatitis. An analysis of his serum revealed B19V DNA and anti-B19V IgG, corroborating bone marrow findings and a persistent B19V infection. The symptoms resolved and B19V became undetectable. In all cases, real time PCR was essential for diagnosing B19V. Our findings showed that adherence to ART was crucial to B19V clearance in HIV-patients and highlighted the importance of the early recognition of B19V disease in unexplained cytopenias.

Keywords: HIV infection; Parvovirus B19; hemolysis; hereditary spherocytosis.

Publication types

  • Case Reports
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Acquired Immunodeficiency Syndrome*
  • Adult
  • Anemia* / diagnosis
  • Anemia* / etiology
  • DNA, Viral / analysis
  • Erythema Infectiosum*
  • HIV / genetics
  • HIV Infections* / complications
  • HIV Infections* / drug therapy
  • Humans
  • Immunoglobulins, Intravenous
  • Male
  • Parvoviridae Infections* / complications
  • Parvoviridae Infections* / diagnosis
  • Parvovirus B19, Human* / genetics

Substances

  • Immunoglobulins, Intravenous
  • DNA, Viral

Grants and funding

We are thankful to the Coordination for the Improvement of Higher Education Personnel—CAPES for the fellowship awarded, and FAPERJ-JCNE (number: e-26/201.406/2021) and the Oswaldo Cruz Institute for funding this study. Instituto Nacional de Infectologia Evandro Chagas was in charge of the publication fee.